SCHEMBL807223

SCHEMBL807223

COc1ncc(-c2ccc3nc(N)c(-c4ccc(C(=O)N5CCOCC5)cc4)c(F)c3c2)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.46
KIT P10721 1/20 0.46
KCNH2 Q12809 4/20 0.45
JAK2 O60674 2/20 0.45
PIK3CD O00329 3/20 0.45
PIK3R1 P27986 1/20 0.45
ATR Q13535 2/20 0.45
MET P08581 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42
LRRK2 Q5S007 1/20 0.42
PIK3CA P42336 4/20 0.41
MTOR P42345 2/20 0.41
NTRK1 P04629 1/20 0.41
PIK3CG P48736 3/20 0.41
HPGD P15428 1/20 0.41
PI4KA P42356 1/20 0.41
BMPR1B O00238 1/20 0.41
BMPR1A P36894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806789 0.88 PIK3CD (0.50) IRAK4KITKCNH2JAK2PIK3CD
SCHEMBL790084 0.80 JAK2 (0.48) KCNH2JAK2ATRPIK3CAHPGD
SCHEMBL806763 0.79 KIT (0.49) IRAK4KITKCNH2PIK3CDPIK3R1
SCHEMBL807212 0.76 PIK3CD (0.46) KITKCNH2JAK2PIK3CDPIK3R1
SCHEMBL807280 0.75 PIK3CD (0.50) KCNH2PIK3CDPIK3R1PIK3CAMTOR
SCHEMBL791064 0.71 PIK3CG (0.81) PIK3CDPIK3R1PIK3CAMTORPIK3CG
SCHEMBL10289033 0.71 PI4KA (0.74) PIK3CDPIK3R1PIK3CAMTORPIK3CG
SCHEMBL807059 0.70 PIK3C3 (0.46) PIK3CGHPGDPI4KA
SCHEMBL12928953 0.70 PIK3CA (0.59) KITPIK3CDPIK3R1PIK3CAMTOR
SCHEMBL10274836 0.69 KCNH2 (0.48) KCNH2PIK3CDMETPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed